Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP279 is a human genomic pseudogene related to 7SK small nuclear RNA. Pseudogenes are DNA sequences similar to known genes but generally nonfunctional; they are often considered genetic relics with no protein-coding capability or regulatory activity. The canonical functional gene in this family is RN7SK, a small nuclear non-coding RNA involved in the regulation of transcription by modulating RNA polymerase II via ribonucleoprotein complexes, but RN7SKP279 does not code a functional RNA and does not participate in these biological processes[1][2][3]. RN7SKP279 is not classified as a receptor, enzyme, transporter, ion channel, or any therapeutic target and has no documented role in disease, drug interactions, or clinical applications[1].\n\nIn summary, RN7SKP279 is a non-functional pseudogene without recognized utility as a molecular target or biomarker, and should not be considered a drug target or receptor[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 279 (RN7SKP279).